Google To Introduce Choice Experience In Chrome Instead Of Deprecating Third-Party Cookies; Will Continue Developing Privacy Sandbox APIs For Enhanced Privacy And Utility; Plans To Add IP Protection To Incognito Mode

Google To Introduce Choice Experience In Chrome Instead Of Deprecating Third-Party Cookies; Will Continue Developing Privacy Sandbox APIs For Enhanced Privacy And Utility; Plans To Add IP Protection

Benzinga12minutes ago

CMA Accepts Google's Commitments On Third-Party Cookies

CMA Accepts Google's Commitments On Third-Party

Benzinga24minutes ago

Meta Platforms Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/22/2024 17.68% Bernstein $565 → $575 Maintains Outperform 07/19/2024 7.45% Oppenheimer $500 → $525

Benzinga33minutes ago · Ratings

AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst

HC Wainwright analyst initiated coverage on AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering immunology therapeutics.AnaptysBio has a pipeline of checkpoint

Benzinga35minutes ago

S&P 500, Nasdaq Rebound, as Nvidia, Tesla and Rest of Magnificent Seven Rally

The

Luzi Ann Santos49minutes ago

The S&P 500 Typically Outperforms in July, Underperforms August-October - RBC Capital Markets

Seeking Alpha14:16 ET